Management of Intracerebral Hemorrhage: Medical Management First, Selective Surgical Intervention
The initial management approach for intracerebral hemorrhage (ICH) should be medical, with surgical intervention reserved for specific clinical scenarios where evidence demonstrates benefit.
Initial Medical Management
Immediate Stabilization
- Secure airway if GCS ≤8 or deteriorating respiratory status 1
- Transport to nearest facility prepared for acute stroke care, ideally with neurocritical care capabilities 2, 1
- Initial care should take place in an ICU or dedicated stroke unit with physician and nursing neuroscience acute care expertise 1
Blood Pressure Management
- Implement intensive lowering of systolic blood pressure to <140 mmHg within six hours of ICH onset 2
- Maintain cerebral perfusion pressure between 50-70 mmHg in patients with ICP monitoring 1
- Avoid hypotension as it adversely affects neurological outcome 1
Reversal of Coagulopathy
- For patients on vitamin K antagonists (e.g., warfarin): administer prothrombin complex concentrate along with vitamin K 2, 1
- For patients on dabigatran: administer idarucizumab 2
- For patients on factor Xa inhibitors: administer andexanet alfa 2
- Correct coagulopathy immediately as it significantly impacts mortality and morbidity 1
Surgical Management Indications
Surgical evacuation is indicated in the following specific scenarios:
Cerebellar hemorrhage with neurological deterioration, brainstem compression, or hydrocephalus from ventricular obstruction (Class I; Level of Evidence B) 2
- Should undergo surgical removal as soon as possible
- Initial treatment with ventricular drainage alone is not recommended
Supratentorial ICH in select cases:
- Patients who are deteriorating neurologically (Class IIb; Level of Evidence C) 2
- Patients in coma with large hematomas with significant midline shift (Class IIb; Level of Evidence C) 2
- Patients with elevated ICP refractory to medical management (Class IIb; Level of Evidence C) 2
- Patients with GCS score 9-12 may benefit from early surgery (weak recommendation) 2
Minimally invasive approaches:
Timing of Surgery
- For cerebellar hemorrhage requiring evacuation: as soon as possible 2
- For supratentorial hemorrhage: timing remains controversial, with some evidence suggesting benefit if performed within 8 hours of hemorrhage 2
- Ultra-early craniotomy (within 4 hours) may be associated with increased risk of rebleeding 2
Prevention of Complications
- Implement intermittent pneumatic compression for prevention of venous thromboembolism beginning on admission day (Class I; Level of Evidence A) 2, 1
- Avoid graduated compression stockings for DVT prophylaxis 2, 1
- Maintain euvolemia rather than hypervolemia 1
- Monitor glucose and avoid both hyperglycemia and hypoglycemia 1
- Formal screening for dysphagia before initiating oral intake 1
Prognosis Factors
Poor prognostic factors include:
- Larger hematoma volume
- Lower initial GCS score
- Presence of intraventricular hemorrhage
- Advanced age (>60 years)
- 30-day mortality rate: 35-52%
- Only about 20% of patients achieve functional independence after 6 months 1
Common Pitfalls to Avoid
- Delaying reversal of anticoagulation: Immediate correction of coagulopathy is essential to prevent hematoma expansion
- Inadequate blood pressure control: Failure to rapidly lower blood pressure can lead to hematoma expansion
- Inappropriate surgical candidate selection: Not all ICH patients benefit from surgery; follow evidence-based criteria
- Overuse of corticosteroids: Should be avoided as they provide no benefit in ICH management 2
- Delayed transfer to specialized centers: Patients should be managed in facilities with neurocritical care expertise
The management of ICH requires a systematic approach with prompt medical intervention and careful selection of surgical candidates based on specific clinical and radiological criteria. While medical management forms the foundation of care for most patients, timely surgical intervention in appropriate cases can be life-saving.